Roche gains RoActemra European Approval for children with RA

Roche has gained approval in Europe for its biologic RoActemra for systemic juvenile idiopathic arthritis. The European Commission has approved the use of RoActemra (tocilizumab) for the treatment of active sJIA in patients two years of age and older who have responded inadequately to previous therapy with non-steroidal anti-inflammatory drugs and systemic corticosteroids (used to

Continue Reading

Roche buys German cancer diagnostics firm

Roche has signed an agreement to acquire mtm laboratories, a privately-held German in vitro diagnostics company which specialises in  early detection of cervical cancer. Under the terms of the deal, the Swiss major will pay shareholders in the Heidelberg-based group an upfront payment of around 130 million euros, plus an extra 60 million euros “upon

Continue Reading